35607-27-3

Basic information

• Product Name: 5-(Pyridin-3-yl)-4H-1,2,4-triazol-3-amine
• Synonyms: 5-(pyridin-3-yl)-4h-1,2,4-triazol-3-amine;3-(3-Pyridyl)-5-amino-1,2,4-triazole;3-Amino-5-(3-pyridyl)-1,2,4-triazole;5-Pyridin-3-yl-4H-[1,2,4]triazol-3-ylamine;[5-(3-pyridyl)-1H-1,2,4-triazol-3-yl]amine;1H-1,2,4-Triazol-3-amine, 5-(3-pyridinyl)-;5-(3-Pyridinyl)-1H-1,2,4-triazol-3-amine;5-(3-pyridyl)-1H-1,2,4-triazol-3-amine
• CAS NO: 35607-27-3
• Molecular Formula: C₇H₇N₅
• Molecular Weight: 161.16
• Mol File: 35607-27-3.mol
• Article Data: 12

Chemical Properties

• Melting Point: 224-225 °C
• Boiling Point: 465.9 °C at 760 mmHg
• Flash Point: 266.7 °C
• Appearance: /
• Density: 1.401
• Vapor Pressure: 7.39E-09mmHg at 25°C
• Refractive Index: 1.686
• CAS DataBase Reference: 5-(Pyridin-3-yl)-4H-1,2,4-triazol-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(Pyridin-3-yl)-4H-1,2,4-triazol-3-amine(35607-27-3)
• EPA Substance Registry System: 5-(Pyridin-3-yl)-4H-1,2,4-triazol-3-amine(35607-27-3)

Safety Data

• Hazardous Substances Data: 35607-27-3(Hazardous Substances Data)

Usage

General Description

5-(Pyridin-3-yl)-4H-1,2,4-triazol-3-amine is a chemical compound with the molecular formula C7H7N5. It is a derivative of triazole and pyridine, containing a triazole ring and a pyridine ring. The compound is commonly used in medicinal chemistry as it exhibits potential biological activities such as antimicrobial, anticancer, and anti-inflammatory properties. It is also used as a building block in the synthesis of various pharmaceutical drugs and agrochemicals. The compound's versatile properties and structural features make it a valuable precursor for the development of new therapeutic compounds for various diseases.

InChI:InChI=1/C7H7N5/c8-7-10-6(11-12-7)5-2-1-3-9-4-5/h1-4H,(H3,8,10,11,12)

Upstream product

• 553-53-7 Nicotinic acid hydrazide 
• 59-67-6 nicotinic acid 
• 2834-84-6 aminoguanidine sulphate 
• 10400-19-8 3-pyridinecarbonyl chloride 
• 46189-75-7 nicotinoylaminoguanidine 
• 1354647-04-3 5-amino-3-(pyridin-3-yl)-1,2,4-triazole hydrochloride 
• 1068-42-4 aminoguanidine sulfate 
• 14527-26-5 2-methylisothiourea sulphate 
• 1937-19-5 1-aminoguanidine hydrochloride 
• 46189-75-7 Nicotinic acid diaminomethylene-hydrazide 
• 10035-10-6 hydrogen bromide 

Downstream Products

• 1338358-62-5 C₁₅H₁₅N₅ 
• 1338351-27-1 N-[(4-fluorophenyl)methyl]-3-(pyridin-3-yl)-1H-1,2,4-triazol-5-amine 
• 1338351-41-9 N-(2-fluorophenyl)-5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazole-1-carboxamide 
• 1338351-42-0 5-[(4-fluorophenyl)methyl]amino-N-methyl-3-(pyridin-3-yl)-1H-1,2,4-triazole-1-carboxamide 
• 1338351-44-2 2-(5-[(4-fluorophenyl)methyl]amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)-1-phenylethan-1-one 
• 122484-49-5 [2-(3,4-Dimethoxy-phenyl)-ethyl]-(5-methyl-2-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine 
• 122484-43-9 7-methyl-2-(3-pyridyl)-5-(3-trifluoromethylphenylamino)-1,2,4-triazolo<1,5-a>pyrimidine 
• 122484-48-4 (3,4-Dichloro-benzyl)-(5-methyl-2-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine 
• 122484-47-3 (3-Fluoro-phenyl)-(5-methyl-2-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine 
• 122484-45-1 (4-Chloro-phenyl)-(5-methyl-2-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine 
• 122484-46-2 (4-Fluoro-phenyl)-(5-methyl-2-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-amine 

Relevant articles and documents

An aqueous medium synthesis and tautomerism study of 3(5)-amino-1,2,4-triazoles

A catalyst-free highly efficient synthesis of 3(5)-amino-5(3)-(het)aryl-1,2,4-triazoles in aqueous medium was performed using conventional heating and microwave irradiation. The tautomerism in the products was investigated using NMR spectroscopy and X-ray crystallography. The effects of the substitution, temperature, solvents, and concentration on the tautomerism were studied. The triazoles were found to exist in 1H-forms, the 4H-form was not observed either in solid state or in solution. In general, 5-amino-1,2,4-triazoles were electronically preferred in the tautomeric equilibrium, but some exceptions from the established relationship were also identified.

Acylated 1 H-1,2,4-Triazol-5-Amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action

We herein report the conventional and microscale parallel synthesis of selective inhibitors of human blood coagulation factor XIIa and thrombin exhibiting a 1,2,4-Triazol-5-Amine scaffold. Structural variations of this scaffold allowed identifying derivative 21i, a potent 29 nM inhibitor of FXIIa, with improved selectivity over other tested serine proteases and also finding compound 21m with 27 nM inhibitory activity toward thrombin. For the first time, acylated 1,2,4-Triazol-5-Amines were proved to have anticoagulant properties and the ability to affect thrombin-And cancer-cell-induced platelet aggregation. Performed mass spectrometric analysis and molecular modeling allowed us to discover previously unknown interactions between the synthesized inhibitors and the active site of FXIIa, which uncovered the mechanistic details of FXIIa inhibition. Synthesized compounds represent a promising starting point for the development of novel antithrombotic drugs or chemical tools for studying the role of FXIIa and thrombin in physiological and pathological processes.

MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN

There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.